Featured
-
-
Article
| Open Access
Human epidermal growth factor receptor-2 expression and subsequent dynamic changes in patients with ovarian cancer
- Yoo-Na Kim
- , Yun Soo Chung
- & Jung-Yun Lee
-
Article
| Open Access
The roles of autophagy, ferroptosis and pyroptosis in the anti-ovarian cancer mechanism of harmine and their crosstalk
- Jun Zhu
- , Hong Zhu
- & Jun Gao
-
Article
| Open Access
Mechanical activation and expression of HSP27 in epithelial ovarian cancer
- Molly Buckley
- , Maranda Kramer
- & Mary Kathryn Sewell-Loftin
-
Article
| Open Access
Targeted inhibition of the ATR/CHK1 pathway overcomes resistance to olaparib and dysregulates DNA damage response protein expression in BRCA2MUT ovarian cancer cells
- Łukasz Biegała
- , Arkadiusz Gajek
- & Aneta Rogalska
-
Article
| Open Access
Characterization and prognostic impact of ACTBL2-positive tumor-infiltrating leukocytes in epithelial ovarian cancer
- N. E. Topalov
- , D. Mayr
- & B. Czogalla
-
Article
| Open Access
Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer
- Nikki L. Burdett
- , Madelynne O. Willis
- & Elizabeth L. Christie
-
Article
| Open Access
Ovarian recurrence risk assessment using machine learning, clinical information, and serum protein levels to predict survival in high grade ovarian cancer
- David P. Mysona
- , Sharad Purohit
- & Sharad Ghamande
-
Article
| Open Access
The role and impact of alternative polyadenylation and miRNA regulation on the expression of the multidrug resistance-associated protein 1 (MRP-1/ABCC1) in epithelial ovarian cancer
- Audrey Marjamaa
- , Bettine Gibbs
- & Chioniso Patience Masamha
-
Article
| Open Access
A multimodal radiomic machine learning approach to predict the LCK expression and clinical prognosis in high-grade serous ovarian cancer
- Feng Zhan
- , Lidan He
- & Lili Wang
-
Article
| Open Access
Validation of the diagnostic efficacy of O-RADS in adnexal masses
- Na Su
- , Ya Yang
- & Yuxin Jiang
-
Article
| Open Access
Prevalence of BRCA homopolymeric indels in an ION Torrent-based tumour-to-germline testing workflow in high-grade ovarian carcinoma
- Jacopo Azzollini
- , Luca Agnelli
- & Siranoush Manoukian
-
Article
| Open Access
Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma
- Robert L. Hollis
- , John P. Thomson
- & C. Simon Herrington
-
Article
| Open Access
Circulating cf-miRNA as a more appropriate surrogate liquid biopsy marker than cfDNA for ovarian cancer
- Aoife Ward Gahlawat
- , Tania Witte
- & Sarah Schott
-
Article
| Open Access
Folate receptor targeted nanoparticles containing niraparib and doxorubicin as a potential candidate for the treatment of high grade serous ovarian cancer
- Lucy Wang
- , James C. Evans
- & Christine Allen
-
Article
| Open Access
Genetic analysis of heterogeneous subsets of circulating tumour cells from high grade serous ovarian carcinoma patients
- Du-Bois Asante
- , Ganendra R. K. A. Mohan
- & Aaron B. Beasley
-
Article
| Open Access
SLC11A2: a promising biomarker and therapeutic target in ovarian cancer
- Liming Tian
- , Xuemei Li
- & Guofen Yang
-
Article
| Open Access
Identification of TP53 mutations in circulating tumour DNA in high grade serous ovarian carcinoma using next generation sequencing technologies
- Leslie Calapre
- , Tindaro Giardina
- & Elin S. Gray
-
Article
| Open Access
The prognosis predictive score around primary debulking surgery (PPSP) improves diagnostic efficacy in predicting the prognosis of ovarian cancer
- Naoki Kawahara
- , Ryuji Kawaguchi
- & Fuminori Kimura
-
Article
| Open Access
Predicting 180-day mortality for women with ovarian cancer using machine learning and patient-reported outcome data
- Chris J. Sidey-Gibbons
- , Charlotte Sun
- & Larissa Meyer
-
Article
| Open Access
Precision gynecologic oncology: circulating cell free DNA epigenomic analysis, artificial intelligence and the accurate detection of ovarian cancer
- Ray O. Bahado-Singh
- , Amin Ibrahim
- & Sangeetha Vishweswaraiah
-
Article
| Open Access
Bexarotene-induced cell death in ovarian cancer cells through Caspase-4-gasdermin E mediated pyroptosis
- Tatsuya Kobayashi
- , Akira Mitsuhashi
- & Makio Shozu
-
Article
| Open Access
Differential epithelial and stromal LGR5 expression in ovarian carcinogenesis
- Hyesung Kim
- , Dong Hui Lee
- & Bogun Jang
-
Article
| Open Access
BRCA1 mutations in high-grade serous ovarian cancer are associated with proteomic changes in DNA repair, splicing, transcription regulation and signaling
- Melissa Bradbury
- , Eva Borràs
- & Anna Santamaria
-
Article
| Open Access
AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin
- Susann Badmann
- , Doris Mayr
- & Bastian Czogalla
-
Article
| Open Access
Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer
- Liv B. Gansmo
- , Nigar Sofiyeva
- & Stian Knappskog
-
Article
| Open Access
Differential expression of hypoxia-inducible factors related to the invasiveness of epithelial ovarian cancer
- Ho-Jun Shih
- , Hsin-Fang Chang
- & Pao-Ling Torng
-
Article
| Open Access
SPME-LC/MS-based serum metabolomic phenotyping for distinguishing ovarian cancer histologic subtypes: a pilot study
- Mariola Olkowicz
- , Hernando Rosales-Solano
- & Janusz Pawliszyn
-
Article
| Open Access
Artificial intelligence-based image analysis can predict outcome in high-grade serous carcinoma via histology alone
- Anna Ray Laury
- , Sami Blom
- & Olli Mikael Carpén
-
Article
| Open Access
Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer
- Szymon Piatek
- , Grzegorz Panek
- & Mariusz Bidzinski
-
Article
| Open Access
Quantitative global lipidomics analysis of patients with ovarian cancer versus benign adnexal mass
- Matthew F. Buas
- , Charles W. Drescher
- & Li Yan
-
Article
| Open Access
A large-scale multi-institutional study evaluating prognostic aspects of positive ascites cytology and effects of therapeutic interventions in epithelial ovarian cancer
- Masato Yoshihara
- , Ryo Emoto
- & Hiroaki Kajiyama
-
Article
| Open Access
Mitochondria in epithelial ovarian carcinoma exhibit abnormal phenotypes and blunted associations with biobehavioral factors
- Snehal Bindra
- , Marlon A. McGill
- & Martin Picard
-
Article
| Open Access
Combination of gene set signatures correlates with response to nivolumab in platinum-resistant ovarian cancer
- Ryusuke Murakami
- , Junzo Hamanishi
- & Masaki Mandai
-
Article
| Open Access
NLR and BRCA mutational status in patients with high grade serous advanced ovarian cancer
- Claudia Marchetti
- , Marco D’Indinosante
- & Anna Fagotti
-
Article
| Open Access
Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality
- Joonas Jukonen
- , Lidia Moyano-Galceran
- & Kaisa Lehti
-
Article
| Open Access
Interleukin-6 as an enhancer of anti-angiogenic therapy for ovarian clear cell carcinoma
- Toshiyuki Seki
- , Nozomu Yanaihara
- & Aikou Okamoto
-
Article
| Open Access
PD-1 and PD-L1 expression on TILs in peritoneal metastases compared to ovarian tumor tissues and its associations with clinical outcome
- Christine Bekos
- , Dietmar Pils
- & Stefanie Aust
-
Article
| Open Access
Stiffness increases with myofibroblast content and collagen density in mesenchymal high grade serous ovarian cancer
- Virginie Mieulet
- , Camille Garnier
- & Fatima Mechta-Grigoriou
-
Article
| Open Access
Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16/CA-125-expressing malignancies
- Marina Stasenko
- , Evan Smith
- & David R. Spriggs
-
Article
| Open Access
Effect of SSRI exposure on the proliferation rate and glucose uptake in breast and ovary cancer cell lines
- Britta Stapel
- , Catharina Melzer
- & Ralf Hass
-
Article
| Open Access
Integrative microRNA and gene expression analysis identifies new epigenetically regulated microRNAs mediating taxane resistance in ovarian cancer
- Mohamed K. Hassan
- , Amr A. Waly
- & Sherif F. El-khamisy
-
Article
| Open Access
Abdominal FLASH irradiation reduces radiation-induced gastrointestinal toxicity for the treatment of ovarian cancer in mice
- Karen Levy
- , Suchitra Natarajan
- & Erinn B. Rankin
-
Article
| Open Access
Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer
- Katharina Leitner
- , Irina Tsibulak
- & Alain G. Zeimet
-
Article
| Open Access
Patient-derived ovarian cancer explants: preserved viability and histopathological features in long-term agitation-based cultures
- Sofia Abreu
- , Fernanda Silva
- & Catarina Brito
-
Article
| Open Access
Optimal scanning concentration of MR imaging for tumor-bearing nude mice with SPIO-shRNA molecular probe
- Liqiang Zhang
- , Xinyi Yang
- & Ming Wen
-
Article
| Open Access
Identification of serum cytokine clusters associated with outcomes in ovarian clear cell carcinoma
- Akira Yabuno
- , Hirokazu Matsushita
- & Kosei Hasegawa
-
Article
| Open Access
Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study
- Alberto Farolfi
- , Emanuela Scarpi
- & Ugo De Giorgi
-
Article
| Open Access
Clinical analysis of conformal and intensity-modulated radiotherapy in patients with recurrent ovarian cancer
- Hua Yang
- , Kaishuo Zhang
- & Li Dai
-
Article
| Open Access
Membrane disruption, but not metabolic rewiring, is the key mechanism of anticancer-action of FASN-inhibitors: a multi-omics analysis in ovarian cancer
- Thomas W. Grunt
- , Astrid Slany
- & Gerald Stübiger
Transcriptome profiling and characterization of peritoneal metastasis ovarian cancer xenografts in humanized mice